Abstract
Increased longevity has been achieved by genetic and environmental manipulations in model organisms, from nematodes to mammals. Genes that can extend life span when altered are referred to as “gerontogenes.” The last several years have seen a dramatic increase in the number of identified gerontogenes (approximately seventy-four). The vast majority of these genes have been identified in the nematode, Caenorhabditis elegans. These genes include age-1 (a phosphatidylinositol 3-OH kinase gene) and daf-2 (an insulin-like receptor gene), as well as genes mediating behavior, metabolism, reproduction and sensory perception. age-1 and daf-2 play a role in a hormonal signaling cascade similar to the mammalian insulin / IGF-1 pathways. The age-1 / daf-2 signal functions to shorten life span and repress the positive regulators of life span, daf-16 and old-1. Similarly, studies of Dwarf mice indicate that the growth hormone-IGF-1 axis may play a role in regulating longevity. Signals from certain tissues, such as sensory neurons and gonads, also regulate life span in C. elegans. The gonadal signal is dependent on the daf-9 cytochrome P450 gene and the daf-12 steroid receptor gene, implicating roles of steroid hormones in longevity. Moreover, increased resistance to intrinsic and environmental stresses [heat, UV, and reactive oxygen species (ROS)] has been shown to be intimately related to increased longevity in a variety of species. ROS scavengers, including superoxide dismutase (SOD) and SOD mimetics, can extend life span in the fruit fly Drosophila melanogaster and in C. elegans, respectively. We suggest that environmental and intrinsic stresses, depending on the evolutionary niche occupied by the species, are key factors that control life span and aging. In summary, cellular signals regulate systemic mechanisms that play a role in stress resistance and also affect longevity.
Current Genomics
Title: Regulation of Life Span in Model Organisms
Volume: 4 Issue: 1
Author(s): Shin Murakami and Thomas E. Johnson
Affiliation:
Abstract: Increased longevity has been achieved by genetic and environmental manipulations in model organisms, from nematodes to mammals. Genes that can extend life span when altered are referred to as “gerontogenes.” The last several years have seen a dramatic increase in the number of identified gerontogenes (approximately seventy-four). The vast majority of these genes have been identified in the nematode, Caenorhabditis elegans. These genes include age-1 (a phosphatidylinositol 3-OH kinase gene) and daf-2 (an insulin-like receptor gene), as well as genes mediating behavior, metabolism, reproduction and sensory perception. age-1 and daf-2 play a role in a hormonal signaling cascade similar to the mammalian insulin / IGF-1 pathways. The age-1 / daf-2 signal functions to shorten life span and repress the positive regulators of life span, daf-16 and old-1. Similarly, studies of Dwarf mice indicate that the growth hormone-IGF-1 axis may play a role in regulating longevity. Signals from certain tissues, such as sensory neurons and gonads, also regulate life span in C. elegans. The gonadal signal is dependent on the daf-9 cytochrome P450 gene and the daf-12 steroid receptor gene, implicating roles of steroid hormones in longevity. Moreover, increased resistance to intrinsic and environmental stresses [heat, UV, and reactive oxygen species (ROS)] has been shown to be intimately related to increased longevity in a variety of species. ROS scavengers, including superoxide dismutase (SOD) and SOD mimetics, can extend life span in the fruit fly Drosophila melanogaster and in C. elegans, respectively. We suggest that environmental and intrinsic stresses, depending on the evolutionary niche occupied by the species, are key factors that control life span and aging. In summary, cellular signals regulate systemic mechanisms that play a role in stress resistance and also affect longevity.
Export Options
About this article
Cite this article as:
Murakami Shin and Johnson E. Thomas, Regulation of Life Span in Model Organisms, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350137
DOI https://dx.doi.org/10.2174/1389202033350137 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index to Volume 5
Current Drug Targets PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research
Current Medicinal Chemistry Vitamin D Measurement in the Intensive Care Unit: Methodology, Clinical Relevance and Interpretation of a Random Value
Inflammation & Allergy - Drug Targets (Discontinued) Mechanisms of CTLA-4-Ig in Tolerance Induction
Current Pharmaceutical Design The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Genetic Factors in Statins Side-Effects
Cardiovascular & Hematological Disorders-Drug Targets Interaction between Microbes and Host Intestinal Health: Modulation by Dietary Nutrients and Gut-Brain-Endocrine-Immune Axis
Current Protein & Peptide Science The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Immobilisation of Cardosin A in Chitosan Sponges as a Novel Implant for Drug Delivery
Current Drug Discovery Technologies The Influence of Hypothalamic Cytokine PRP on Protein Synthesis in Brain Subcellular Compartments in Crush Syndrome
Central Nervous System Agents in Medicinal Chemistry Studying the Human Gut Microbiota in the Trans-Omics Era - Focus on Metagenomics and Metabonomics
Current Pharmaceutical Design Targeting Angiogenesis in Gastro-Intestinal Non Colorectal Cancers; A Review
Current Angiogenesis (Discontinued) Pain and Child: A Translational Hypothesis on the Pathophysiology of a Mild Type-2 Diabetes Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Implications of Beta-Adrenergic Receptor Pharmacodynamic Properties
Current Clinical Pharmacology Pharmacologically Targeting the Primary Defect and Downstream Pathology in Duchenne Muscular Dystrophy
Current Gene Therapy Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
Anti-Cancer Agents in Medicinal Chemistry Melatonin, Immune Function and Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Diabetes and Heart Failure: Is it Hyperglycemia or Hyperinsulinemia?
Current Vascular Pharmacology Cellular Senescence in Ageing, Age-Related Disease and Longevity
Current Vascular Pharmacology